Cargando…

Interactions of SARS-CoV-2 with the Blood–Brain Barrier

Emerging data indicate that neurological complications occur as a consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The blood–brain barrier (BBB) is a critical interface that regulates entry of circulating molecules into the CNS, and is regulated by signals that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Erickson, Michelle A., Rhea, Elizabeth M., Knopp, Rachel C., Banks, William A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961671/ https://www.ncbi.nlm.nih.gov/pubmed/33800954 http://dx.doi.org/10.3390/ijms22052681

Ejemplares similares

The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice
por: Rhea, Elizabeth M., et al.
Publicado: (2021)

SARS-CoV-2, the blood-brain barrier, and neuroinflammation
por: Banks, William A
Publicado: (2023)

The Blood–Brain Barrier, Oxidative Stress, and Insulin Resistance
por: Banks, William A., et al.
Publicado: (2021)

Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance
por: Rhea, Elizabeth M., et al.
Publicado: (2019)

The Effects of Viruses on Insulin Sensitivity and Blood–Brain Barrier Function
por: Raber, Jacob, et al.
Publicado: (2023)

Neuroimmune Axes of the Blood–Brain Barriers and Blood–Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions
por: Erickson, Michelle A., et al.
Publicado: (2018)

Age-Associated Changes in the Immune System and Blood–Brain Barrier Functions
por: Erickson, Michelle A., et al.
Publicado: (2019)

Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer’s disease
por: Erickson, Michelle A., et al.
Publicado: (2023)

Effects of Rapamycin on Insulin Brain Endothelial Cell Binding and Blood–Brain Barrier Transport
por: Nguyen, Steven, et al.
Publicado: (2021)

The impact of acute rosiglitazone on insulin pharmacokinetics at the blood‐brain barrier
por: Galindo, Demi C., et al.
Publicado: (2020)

Endocytosis of insulin at the blood-brain barrier
por: Pemberton, Sarah, et al.
Publicado: (2022)

In vitro modeling of blood–brain barrier and interface functions in neuroimmune communication
por: Erickson, Michelle A., et al.
Publicado: (2020)

Ultrastructural Remodeling of the Blood–Brain Barrier and Neurovascular Unit by Lipopolysaccharide-Induced Neuroinflammation
por: Erickson, Michelle A., et al.
Publicado: (2023)

Pitavastatin Ameliorates Lipopolysaccharide-Induced Blood-Brain Barrier Dysfunction
por: Fujimoto, Takashi, et al.
Publicado: (2021)

Genetics and sex influence peripheral and central innate immune responses and blood-brain barrier integrity
por: Erickson, Michelle A., et al.
Publicado: (2018)

Ghrelin transport across the blood–brain barrier can occur independently of the growth hormone secretagogue receptor
por: Rhea, Elizabeth M., et al.
Publicado: (2018)

Blood-brain Barrier Damage is Pivotal for SARS-CoV-2 Infection to the Central Nervous System
por: Rodríguez-Morales, Jahir, et al.
Publicado: (2022)

Characteristics of compounds that cross the blood-brain barrier
por: Banks, William A
Publicado: (2009)

Amyloid Beta Pathology Exacerbates Weight Loss and Brain Cytokine Responses following Low-Dose Lipopolysaccharide in Aged Female Tg2576 Mice
por: Knopp, Rachel C., et al.
Publicado: (2022)

The SARS-CoV-2 envelope protein disrupts barrier function in an in vitro human blood-brain barrier model
por: Ju, Jiahang, et al.
Publicado: (2022)

SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids
por: Pellegrini, Laura, et al.
Publicado: (2020)

SARS-CoV-2-mediated encephalitis: Role of AT2R receptors in the blood-brain barrier
por: de Sousa, Antônio Kleiton, et al.
Publicado: (2020)

The Bradykinin B2 Receptor Agonist (NG291) Causes Rapid Onset of Transient Blood–Brain Barrier Disruption Without Evidence of Early Brain Injury
por: Rodríguez-Massó, Sergio R., et al.
Publicado: (2021)

Role of the blood–brain barrier in the evolution of feeding and cognition
por: Banks, William A
Publicado: (2012)

SARS-CoV-2 Spike Protein Disrupts Blood–Brain Barrier Integrity via RhoA Activation
por: DeOre, Brandon J., et al.
Publicado: (2021)

Lipopolysaccharide impairs amyloid beta efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood–brain barrier
por: Erickson, Michelle A, et al.
Publicado: (2012)

SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier
por: Stüdle, Chiara, et al.
Publicado: (2023)

Quantum Dot Biomimetic for SARS-CoV-2 to Interrogate Blood–Brain Barrier Damage Relevant to NeuroCOVID Brain Inflammation
por: Chiang, Wesley, et al.
Publicado: (2023)

The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2
por: Krasemann, Susanne, et al.
Publicado: (2022)

SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects
por: Constant, Orianne, et al.
Publicado: (2021)

Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
por: Burks, Susan M., et al.
Publicado: (2021)

Differential effects of SARS-CoV-2 variants on central nervous system cells and blood–brain barrier functions
por: Proust, Alizé, et al.
Publicado: (2023)

Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease
por: Banks, William A
Publicado: (2008)

Intranasal Delivery: Effects on the Neuroimmune Axes and Treatment of Neuroinflammation
por: Rhea, Elizabeth M., et al.
Publicado: (2020)

Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions
por: Gavor, Edem, et al.
Publicado: (2020)

Triglycerides cross the blood–brain barrier and induce central leptin and insulin receptor resistance
por: Banks, W A, et al.
Publicado: (2018)

Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection
por: Alquisiras-Burgos, Iván, et al.
Publicado: (2020)

SARS-CoV-2 crosses the blood–brain barrier accompanied with basement membrane disruption without tight junctions alteration
por: Zhang, Ling, et al.
Publicado: (2021)

The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier
por: Buzhdygan, Tetyana P., et al.
Publicado: (2020)

Recombinant human plasma gelsolin reverses increased permeability of the blood–brain barrier induced by the spike protein of the SARS-CoV-2 virus
por: Suprewicz, Łukasz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jeo52p8bfi2l4tovhil01kmdu7